Finasteride vs Minoxidil vs PRP vs Transplant Surgery
How does finasteride compare to minoxidil, PRP and hair transplant surgery?
Most people line these four up like competitors and pick a winner, but they're not doing the same job. One slows the cause, one nudges growth, one signals the follicles you still have, and one moves hair you already own from the back of your head to the front. Get that straight and the choice stops being a shopping decision and starts being a sequence.
- Finasteride: The only one acting on the cause, lowering DHT at one milligram daily.
- Topical minoxidil: Works downstream, prolonging the growth phase, with modest regrowth strongest at the vertex.
- Platelet-rich plasma: Your own concentrated platelets injected into the scalp, adjunctive rather than foundational.
- Transplant surgery: Redistributes androgen-resistant donor follicles, the only option that adds hair where none remains.
Finasteride at one milligram daily is the only one of the four that lowers DHT and slows the cause of androgenetic alopecia, minoxidil and platelet-rich plasma stimulate follicles that are still cycling, and surgery is the only option that can add hair where the follicles are already gone.
What is the mechanism of action behind each of these four treatments?
The reason you can't swap one of these for another is that they act at four different levels of the same biology. Finasteride works on the hormone, minoxidil on the follicle's growth switch, platelet-rich plasma on the signaling around it, and surgery on nothing pharmacological at all.
- 5-alpha-reductase inhibition: One milligram daily cuts circulating DHT by roughly two thirds.
- Potassium channel opening: Sulfotransferase converts minoxidil in the root sheath, prolonging anagen and improving blood supply.
- Growth factor signaling: Concentrated platelets release platelet-derived and vascular growth factors into the scalp.
- Donor dominance: Grafted follicles keep the androgen resistance of the occipital zone they came from.
Finasteride at one milligram daily reduces circulating DHT by roughly two thirds, minoxidil sulfate acts as a potassium channel opener that prolongs the growth phase, platelet-rich plasma delivers concentrated growth factors to the dermal papilla, and transplanted follicles keep growing through donor dominance rather than any continuing drug effect.
How strong is the clinical evidence behind each of these options?
Here's what most people get wrong about evidence: how heavily something gets marketed tells you nothing about how well it's been studied. Two of these four went through large placebo-controlled trials with hair counts and blinded photography, one rests on a stack of small studies that each used a different recipe, and one can't be randomized at all.
Finasteride and topical minoxidil carry regulatory approval for androgenetic alopecia on the strength of large multicenter placebo-controlled trials using quantitative hair counts, platelet-rich plasma rests on small studies whose protocols vary so widely that a pooled result averages procedures that aren't the same intervention, and surgical evidence is observational because a sham operation can't be blinded.
Which of these treatments stop further loss and which actually regrow hair?
Confusing holding the line with getting hair back is the fastest way to decide a treatment failed when it did exactly what it was built to do. Finasteride mostly defends what you've still got. Only surgery puts hair into a patch where the follicles are already gone.
| Criteria | Finasteride | Minoxidil | Surgery |
|---|---|---|---|
| Main effect | Stops further loss | Modest regrowth | Adds hair |
| Strongest area | Vertex and mid-scalp | Vertex | Wherever grafts are placed |
| Protects native hair | Yes | No | No |
| Works on bare scalp | No | No | Yes |
In the pivotal trials the large majority of men on finasteride showed no further visible loss at one and two years while the placebo group kept declining, minoxidil delivers modest regrowth concentrated at the vertex, and surgery is the only option that adds hair to an area where the follicles have already been lost.
How do the side effect and risk profiles of these treatments compare?
Don't compare these risks by how often something happens. Compare them by whether you can undo it, because the drugs hand you effects that usually fade when you stop, while surgery hands you a donor zone you only get to spend once.
Finasteride and minoxidil carry low-frequency, generally reversible adverse effects reported by a low single-digit percentage of men in the controlled trials, while surgery is the only option on this list with irreversible downsides including donor scarring, lasting numbness, shock loss and a permanently depleted donor supply.
What does each treatment cost up front and over a ten year horizon?
The cheapest option on day one isn't the cheapest option in year ten, and that reversal is where most hair restoration budgets go wrong. Two of these are small monthly bills that never stop, one is a big invoice you mostly pay once, and one quietly outspends surgery if you keep it going for a decade. Treat every figure here as illustrative, since pricing swings sharply by country, city and clinic.
| Criteria | Generic drugs | Platelet-rich plasma | Transplant surgery |
|---|---|---|---|
| Unit price | $10 to $40 a month | Few hundred to $1,000+ a session | A few dollars per graft |
| First year | Low hundreds | Thousands, over 3 to 4 sessions | Mid four to low five figures |
| Ten year picture | Low four figures | Can exceed surgery | Front-loaded, often a second procedure |
| Still paying after? | Indefinitely | Every 3 to 6 months | Drugs continue alongside |
Generic finasteride at roughly ten to thirty dollars a month and topical minoxidil at fifteen to forty dollars a month put a decade of medical therapy in the low four figures, while platelet-rich plasma maintenance one to three times a year can quietly exceed the mid four to low five figure cost of a transplant that still leaves you buying drugs.
What ongoing commitment does each option require to keep the result?
Three of these four only hold their result while you keep going, so what you're really picking is a routine you'll still be following in five years. Adherence is the quiet variable, and a cheap treatment you use half the time returns less than a costly one you use properly.
Stopping finasteride returns dihydrotestosterone to its pretreatment level and gives back several years of protected hair within about twelve months, minoxidil-held hairs are commonly shed within three to four months of the last dose, platelet-rich plasma needs repeat injections every three to six months, and only grafted follicles normally grow for life without further treatment.
Which stage and pattern of hair loss suits each treatment?
Stage narrows the shortlist before your preference gets a say. The question that decides it is simple: under good light, is there still fine hair in the thinning area, or is the skin smooth and shiny? Living miniaturized follicles can be treated, and bare scalp can only be grafted.
Medical therapy only works where miniaturized but living follicles remain, typically early to moderate recession and thinning at the vertex and mid-scalp, grafting is the only option for scalp that is genuinely bald, and how many grafts you can ever move is capped by donor density and scalp laxity rather than by the size of the area you want covered.
How are these treatments used together rather than chosen one over another?
Treating these four as rivals is mostly a marketing habit. In practice they get layered, and the base layer is a hormonal blocker plus a follicular stimulant, because the two mechanisms don't overlap. Surgery goes on top of that, never instead of it.
- Diagnose and stage: Confirm the loss is androgenetic and take baseline photography before anything changes.
- Start the pair: Comparative studies of combined finasteride and minoxidil generally report better density than either drug alone.
- Reassess at six and twelve months: Stagger anything new by a few weeks so you can tell what worked and what caused a side effect.
- Add platelet-rich plasma if you've plateaued: It works as an adjunct, including around a surgical date, though that perioperative evidence is thinner than the enthusiasm for it.
- Then talk surgery: Once loss is stabilized, grafts fill the defined deficit that drugs can't reach.
The clinical baseline is a DHT blocker plus a follicular stimulant, since comparative studies of finasteride and minoxidil together generally report better density than either alone, with platelet-rich plasma layered on as an adjunct and surgery reserved for a defined deficit that medical therapy has already stabilized.
Which of these options are appropriate for women, and how does that change the comparison?
For women this comparison narrows hard at one end and opens up at the other. Finasteride is the constrained option, because 5-alpha-reductase inhibition can cause abnormalities of the external genitalia in a male fetus. Topical minoxidil is the one standing on the firmest ground.
- Finasteride: Contraindicated in pregnancy, and off label in postmenopausal women with more modest results.
- Topical minoxidil: Two percent twice daily and five percent foam once daily are both established.
- Transplant surgery: Stricter selection, since loss is diffuse and the donor area is often thinning too.
- Workup first: Iron studies, thyroid function and a medication review frequently change the plan entirely.
Finasteride is contraindicated in pregnancy and is either avoided or used only with reliable contraception and explicit counseling in premenopausal women, while two percent topical minoxidil twice daily and five percent foam once daily are the options established for female pattern hair loss on placebo-controlled data.
How long does each treatment take to show a visible result?
Every timeline on this list belongs to the hair cycle, not to the treatment. A resting phase runs roughly three months, so a follicle can't show you a changed trajectory until it has turned over at least once. Judge any of these sooner than that and you're judging the biology before it has reported.
Finasteride needs at least three months of daily use before any benefit shows and deserves its verdict at twelve months, minoxidil causes a transient shed in the first two weeks with genuine cosmetic change from three to four months and best results by six to eight, platelet-rich plasma responders notice change three to six months after an induction series, and transplanted hairs shed before new growth appears at three to six months and matures by six to twelve.
